The FDA-cleared ChemWell® RPR replaces the manual labor-intensive and subjective visual RPR reading with a fully automatic, 190 results-per-hour process that objectively interprets and stores photographic images. Over the years and around the world many high throughput labs have already given up the advantages of non-treponemal screening, replacing it with more expensive treponemal ELISA testing simply to take advantage of automation. The compromise is no longer necessary.
Automated ChemWell® RPR allows laboratories to use the US CDC recommended traditional nontreponemal screening algorithm instead of the higher-cost and complicated reverse algorithm while reducing hands-on time by 92%, compared to a manual RPR test.
The innovative test system was developed in cooperation with Arlington Scientific Inc. (Salt Lake City, Utah USA) who is selling in North America and Europe under the brand name Evolution. Awareness Technology will supply the rest of the world through its distribution and technical service channels.